维普期刊资源整合服务平台（V6.5）

675篇 您的检索式：期刊名="Curr Drug Metab"

选中清除导出查看参考文献查看引证文献引用追踪共34页首页上一页第1页下一页末页 /34 跳转

	题名	作者	年代	出处	被引量
1	Predicting the pharmacokinetics of acyl glucuronides and their parent compounds in disease states 显示文摘	Liu JH Smith PC	2006	Curr Drug Metab2006，7，：	1
2	The role of mass-spectrometry in biomarker discovery and measurement显示文摘	Ackermann BL Hale JE Duffin KL	2006	Curr Drug Metab2006，7，5：	1
3	A review of the pharmacological interactions of ivermectin in several animal species 显示文摘	Gonzalez-Canga A Fernandez-Maetinez N Sahaqun-Prieto A	2009	Curr Drug Metab2009，10，4：	1
4	Mechanisms of increased vascular oxidant stress inhyperhomocys-teinemia and its impact on endothelial func-tion显示文摘	Weiss N	2005	Curr Drug Metab2005，6，1：	1
5	Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function 显示文摘	Weiss N	2005	Curr Drug Metab2005，6，1：	1
6	Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism显示文摘	Zhang Z Gao F Jiang S	2012	Curr Drug Metab2012，13，8：	1
7	In vitro methods to study intestinal drug metabolism显示文摘	van de Kerkhof Esther G de Graaf	2007	Curr Drug Metab2007，8，7：	1
8	A carboxylesterase 2 gene polymorphism as predictor of capecitabine on response and time to progression显示文摘	Ribelles N Lopez-Siles J Sanchez A	2008	Curr Drug Metab2008，9，4：	1
9	Regioselective Sulfation and Glucuronidation of Phenolics: Insights into the Structural Basis of Conjugation显示文摘	Baojian W Sumit B Shengnan M	2011	Curr Drug Metab2011，12，9：	1
10	Chinese herbs as immunomodulators and potential disease-modifying antirheumatic drugs in autoimmune disorders显示文摘	Ho LJ Lai JH	2004	Curr Drug Metab2004，5，2：	1
11	All? hydrolysis-dependem multidrug effiux transporter: MDR1/p-glycopmtein显示文摘	Kimura Y Matsuo M Takahashi K	2004	Curr Drug Metab2004，3，1：	1
12	ATP hydrolysis-dependent multidrug efflux transporter:MDR1/P-glycoprotein显示文摘	Kimura Y Matsuo M Takahashi K Saeki T Kioka N Amachi T	2004	Curr Drug Metab2004，5，1：	1
13	Age-related changes in pharmacokinetics 显示文摘	Shi S Klotz U	2011	Curr Drug Metab2011，12，7：	1
14	Morphofunctional aspects of the Blood-Brain Barrier 显示文摘	Nico B Ribatti D	2012	Curr Drug Metab2012，13，1：	1
15	Cytochrome P450 and anticancer drugs 显示文摘	Fujita K	2006	Curr Drug Metab2006，7，1：	1
16	CYP3A4 induction by xenobiotics:biochemistry,experimental methods and impact on drug discovery and development显示文摘	LUO G GUENTHNER T GAN L S	2004	Curr Drug Metab2004，5，6：	1
17	Resveratrol: a natural polyphenol with multiple chemopreventive properties显示文摘	Brisdelli F D'Andrea G Bozzi A	2009	Curr Drug Metab2009，10，6：	1
18	Cytochrome P450 gene polymorphism and cancer显示文摘	Agundez JA	2004	Curr Drug Metab2004，5，3：	1
19	Pharmacogenetic variation and metformin response显示文摘	Chen S Zhou J Xi M	2013	Curr Drug Metab2013，14，10：	1
20	Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria显示文摘	Cashman JR Camp K Fakharzadeh SS Fennessey PV Hines RN Mamer OA	2003	Curr Drug Metab2003，4，2：	1

返回顶部每页显示：

共34页首页上一页第1页下一页末页 /34 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示